Cellect Biotechnology logo

APOP - Cellect Biotechnology News Story

$3.17 0.0  0.3%

Last Trade - 22/01/21

Sector
Healthcare
Size
Micro Cap
Market Cap £5.28m
Enterprise Value £805k
Revenue £n/a
Position in Universe 6152nd / 6630

BRIEF-Cellect Biotechnology Reports Second Quarter Financial And Operating Results

Wed 12th August, 2020 2:37pm
Aug 12 (Reuters) - Cellect Biotechnology Ltd  APOP.O :
    * CELLECT BIOTECHNOLOGY REPORTS SECOND QUARTER FINANCIAL AND
OPERATING RESULTS; FIRST HALF 2020 STRATEGIC DEVELOPMENTS CREATE
LONG-TERM REVENUE CATALYSTS
    * Q2 LOSS PER SHARE $0.007

Source text for Eikon:  ID:nPnTfg2Ga 
Further company coverage:  APOP.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.